Updated ASCO recommendations for the use of white blood cell growth factors.
Dale
David C
DC
University of Washington Medical Center, Seattle, WA 98195, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003115:Colony-Stimulating Factors / Q000009:adverse effects / Q000592:standards* / Q000627:therapeutic use*; D005334:Fever / Q000139:chemically induced / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D012307:Risk Factors; D012955:Societies, Medical; D014481:United States
D003115:Colony-Stimulating Factors